Patents by Inventor Paul Satoh

Paul Satoh has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7794699
    Abstract: An improved synthetic blood substitute which exhibits excellent long-term storage stability at both high and low temperatures is suitable for use in various biomedical and biotechnical applications, including resuscitation of trauma victims that have suffered massive hemorrhaging, and transfusions for human and veterinary surgical procedures. The artificial blood solution comprises an aqueous carrier, and a dendritic polymer that is capable of carrying oxygen dissolved in the aqueous carrier. The dendritic polymer comprises fluorocarbon moieties and hydrophilic moieties.
    Type: Grant
    Filed: January 4, 2006
    Date of Patent: September 14, 2010
    Assignee: Michigan Molecular Institute
    Inventors: Steven N. Kaganove, Paul Satoh, Petar R. Dvornic
  • Publication number: 20060216196
    Abstract: A device and methods for the rapid chemiluminescence or calorimetric assay of surfaces to detect the presence of microbial or protein contamination is disclosed. A sampling/analysis member (10) is described having a sampling wand (15) which is suitable for use by untrained personnel under the relatively harsh and variable conditions found in the field, for example in fast food restaurants and other food preparation areas. The analytical signal in the disclosed device and methods can be based on luciferase/luciferin systems or a protein assay systems utilizing bicinchoninic acid.
    Type: Application
    Filed: March 23, 2005
    Publication date: September 28, 2006
    Applicant: Neogen Corporation
    Inventors: Paul Satoh, Donald Pielack, James Topper, Clifton Brown
  • Publication number: 20060166367
    Abstract: A test device for detecting the presence of protein or other reducing compound wherein a bicinchoninic acid or salt composition is in a sampling swab (27) on a sampling wand (17) is separate from a dried cupric salt on a disc (48) in an essentially transparent well (45). The reaction of protein with the cupric salt in the well in the presence of the composition reduces Cu+2 to Cu+1 which forms a deep purple complex with the bicinchoninic acid or salt and which can be detected visually or by a spectophotometric device (10) or other detection instruments. The result determines whether or not surface is contaminated with protein or other reducing compound and thus is unsanitary.
    Type: Application
    Filed: January 27, 2005
    Publication date: July 27, 2006
    Applicant: Neogen Corporation
    Inventors: Paul Satoh, James Herbert, Brinton Miller
  • Publication number: 20060147414
    Abstract: An improved synthetic blood substitute which exhibits excellent long-term storage stability at both high and low temperatures is suitable for use in various biomedical and biotechnical applications, including resuscitation of trauma victims that have suffered massive hemorrhaging, and transfusions for human and veterinary surgical procedures. The artificial blood solution comprises an aqueous carrier, and a dendritic polymer that is capable of carrying oxygen dissolved in the aqueous carrier. The dendritic polymer comprises fluorocarbon moieties and hydrophilic moieties.
    Type: Application
    Filed: January 4, 2006
    Publication date: July 6, 2006
    Inventors: Steven Kaganove, Paul Satoh, Petar Dvornic